Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWCefsulodin is a cephalosporin antibiotic.1 It is active against 45 isolates of P. aeruginosa (MIC90 = 3.1 µg/ml) and acts synergistically against P. aeruginosa isolates when combined with gentamicin, tobramycin (Item No. 14596), amikacin (Item No. 15405), or mezlocillin (Item No. 30691). Cefsulodin is also active against isolates of S. aureus, S. epidermidis, S. pneumoniae, and S. pyogenes (MIC90s = 8, 8, 12, and 12 µg/ml, respectively). It binds to P. aeruginosa penicillin-binding protein 1a (PBP1a), PBP1b, and PBP3 but not PBP2, PBP4, or PBP5.2 It increases survival in mice infected with various P. aeruginosa strains (ED50s = 1.93-137 mg/kg for all).3 Formulations containing cefsulodin have been used in the treatment of P. aeruginosa infections.
WARNING This product is not for human or veterinary use.
1. Activity of cefsulodin and other agents against Pseudomonas aeruginosa. Rev. Infect. Dis. 6 (Suppl. 3), S667-S677 (1984).
2. Comparative studies of penicillin-
3. Comparative in vivo activities of cefsulodin, sulbenicillin, and gentamicin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 14(1), 151-153 (1978).